UK Companies House feature
IQVIA LTD.
Profile
- Company number
- 03022416
- Status
- Active
- Incorporation
- 1995-02-15
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62090
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“We have concluded that the use of the going concern basis of accounting in the preparation of the financial statements is appropriate. However, because not all future events or conditions can be predicted, this conclusion is not a guarantee as to the company’s ability to continue as a going concern.”
Subsidiaries
- Q Squared Solutions Holdings Limited · 60% held · United Kingdom · Holding Company
- Clintec Luxembourg S.A. · 100% held · Luxembourg · Holding Company
- Clinical Lab Minority Shareholder Limited · 100% held · United Kingdom · Lab
- IQVIA RDS Austria GmbH · 100% held · Austria · Clinical Research
- IQVIA RDS Pty. Limited · 100% held · Australia · Clinical Research
Significant events
- “On 4 March 2024, the company acquired the entire issued share capital of Arc Bio Communications Limited for £18.50 million.”
- “On 2 May 2024, the company acquired the entire issued share capital of Ceuta Holdings Limited.”
- “On 27 June 2024 the company acquired the trade and assets of Healthcare Business Information Limited for £10.60 million.”
- “In addition, on 28 June 2024 the company acquired the trade and assets of LH Perspectives Limited for £34.33 million.”
- “During December 2024 the company reorganised its investment in the PharmaReview group which resulted in: £47.90 million spent to acquire PharmaReview Limited; £56 million spent to acquire Pharmaspectra Group Ltd.”
- “On 13 May 2025, the company sold the entire issued share capital of Ceuta Holdings Limited, for £62.67m, to IQVIA IES European Holdings.”
- “On 11 June 2025, the company acquired the shares of Medicines Evaluation Unit Limited and CRO Solutions Limited for £122.8m.”
- “On 1 July 2025, the company acquired the trade of PharmaReview Limited for £47.91m and also the entire issued share capital of Apira Limited for £11.13m.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-21 | — | — |
| BERKSHIRE, James Grant | Director | 2020-02-07 | Jun 1973 | British |
| KOTCHIE, Natalia Alexandra | Director | 2020-10-08 | May 1985 | American |
| RANDALL, Kerry Louise | Director | 2023-11-28 | Jul 1980 | British |
| SHEPPARD, Timothy Peter | Director | 2020-02-07 | Jan 1971 | British |
| TURLAND, Kevin John | Director | 2014-02-28 | Mar 1969 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WILSON, Michael Norman | Secretary | 1995-02-15 | 2014-02-28 |
| HALCO SECRETARIES LIMITED | Corporate Secretary | 2018-04-10 | 2023-06-21 |
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 1995-02-15 | 1995-02-15 |
| GILLINGS, Dennis Barry, Dr | Director | 1995-02-15 | 1999-12-23 |
| GOODACRE, John | Director | 1999-12-23 | 2015-12-17 |
| LATTIMORE, Barry Keith | Director | 2018-12-18 | 2020-05-29 |
| MACDONALD, Alasdair | Director | 2000-07-31 | 2018-12-31 |
| REYNDERS, Ludo, Dr | Director | 1995-02-15 | 2004-06-10 |
| WILSON, Michael Norman | Director | 1995-02-15 | 2014-02-28 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 1995-02-15 | 1995-02-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Quintiles Holdings | Legal person | Shares 75–100% | 2016-04-06 | Ceased 2016-04-06 |
| Iqvia Rds Holdings | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 169 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-24 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-10-08 | AA | accounts | accounts with accounts type full |
| 2025-07-09 | CH01 | officers | change person director company with change date |
| 2025-02-21 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-12-12 | RESOLUTIONS | resolution | resolution |
| 2024-12-09 | SH01 | capital | capital allotment shares |
| 2024-09-23 | AA | accounts | accounts with accounts type full |
| 2024-02-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-11-30 | AP01 | officers | appoint person director company with name date |
| 2023-11-06 | CH01 | officers | change person director company with change date |
| 2023-10-09 | AD02 | address | change sail address company with old address new address |
| 2023-10-06 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-10-06 | TM02 | officers | termination secretary company with name termination date |
| 2023-10-06 | AA | accounts | accounts with accounts type full |
| 2023-04-27 | SH19 | capital | capital statement capital company with date currency figure |
| 2023-04-27 | RESOLUTIONS | resolution | resolution |
| 2023-04-27 | CAP-SS | insolvency | legacy |
| 2023-04-27 | SH20 | capital | legacy |
| 2023-04-17 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-02-28 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.